These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 16765651

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Is there a risk for lymphoma or extracolonic cancer in patients with inflammatory bowel disease?
    Toader E, Ciortescu I.
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):368-74. PubMed ID: 24340518
    [Abstract] [Full Text] [Related]

  • 23. A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis.
    Lobel EZ, Korelitz BI, Xuereb MA, Panagopoulos G.
    Am J Gastroenterol; 2004 Mar; 99(3):462-5. PubMed ID: 15056086
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
    Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB.
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
    Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD.
    Gut; 2005 Aug; 54(8):1121-5. PubMed ID: 16009685
    [Abstract] [Full Text] [Related]

  • 32. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
    Broekman MMTJ, Coenen MJH, van Marrewijk CJ, Wanten GJA, Wong DR, Verbeek ALM, Klungel OH, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, de Jong DJ, TOPIC Recruitment Team.
    Inflamm Bowel Dis; 2017 Oct; 23(10):1873-1881. PubMed ID: 28644183
    [Abstract] [Full Text] [Related]

  • 33. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C, Magowan S, Accortt NA, Chen J, Stone CD.
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: a systematic review of the literature and a survey of Canadian gastroenterologists.
    Wallace TM, Veldhuyzen van Zanten SJ.
    Can J Gastroenterol; 2001 Jan; 15(1):21-8. PubMed ID: 11173323
    [Abstract] [Full Text] [Related]

  • 39. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ, Gearry RB, Begg EJ, Zhang M, Barclay ML.
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [Abstract] [Full Text] [Related]

  • 40. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
    Gisbert JP, Niño P, Rodrigo L, Cara C, Guijarro LG.
    Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.